207 related articles for article (PubMed ID: 11877580)
1. Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.
Wang AY; Yu AW; Lam CW; Yu LM; Li PK; Goh J; Lui SF
Am J Kidney Dis; 2002 Mar; 39(3):600-8. PubMed ID: 11877580
[TBL] [Abstract][Full Text] [Related]
2. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
Jimeno L; Rodado R; Barrios Y; Campos M; Llorente S; Nicolas F; Minguela A
Transplant Proc; 2005 Mar; 37(2):1012-3. PubMed ID: 15848608
[TBL] [Abstract][Full Text] [Related]
3. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant erythrocytosis: a model for the investigation of the pharmacological control of renal erythropoietin production?
Gleiter CH
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):489-92. PubMed ID: 8937931
[TBL] [Abstract][Full Text] [Related]
6. Serum stem cell factor level in renal transplant recipients with posttransplant erythrocytosis.
Kiykim AA; Genctoy G; Horoz M; Tiftik NE; Gok E; Altun B; Arici M; Haznedaroglu I
Artif Organs; 2009 Dec; 33(12):1086-90. PubMed ID: 19958348
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism.
Danovitch GM; Jamgotchian NJ; Eggena PH; Paul W; Barrett JD; Wilkinson A; Lee DB
Transplantation; 1995 Jul; 60(2):132-7. PubMed ID: 7624954
[TBL] [Abstract][Full Text] [Related]
8. Effect of enalapril on exaggerated erythropoietin response to phlebotomy in erythrocytosic renal transplant patients.
Usalan C; Erdem Y; Cağlar M; Altun B; Arici M; Bakkaloğlu M; Yasavul U; Turgan C; Cağlar S
Nephrol Dial Transplant; 1998 Nov; 13(11):2884-9. PubMed ID: 9829495
[TBL] [Abstract][Full Text] [Related]
9. Ramipril in post-renal transplant erythrocytosis.
Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
[TBL] [Abstract][Full Text] [Related]
10. Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis.
Ersoy A; Kahvecioglu S; Ersoy C; Cift A; Dilek K
Transplant Proc; 2005 Jun; 37(5):2148-50. PubMed ID: 15964363
[TBL] [Abstract][Full Text] [Related]
11. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
[TBL] [Abstract][Full Text] [Related]
12. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin system polymorphisms and hemoglobin level in renal allografts: a comparative study between losartan and enalapril.
Noroozianavval M; Argani H; Aghaeishahsavari M; Veisi P; Ghorbanihaghjo A; Rashtchizadeh N; Jabbarpourbonyadi M; Hamzeiy H
Transplant Proc; 2007 May; 39(4):1018-22. PubMed ID: 17524880
[TBL] [Abstract][Full Text] [Related]
14. Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: role of growth factors and cytokines.
Morrone LF; Di Paolo S; Logoluso F; Schena A; Stallone G; Giorgino F; Schena FP
Transplantation; 1997 Sep; 64(6):913-8. PubMed ID: 9326420
[TBL] [Abstract][Full Text] [Related]
15. Correction of posttransplant erythrocytosis with enalapril.
Rell K; Koziak K; Jarzyo I; Lao M; Gaciong Z
Transplantation; 1994 Apr; 57(7):1059-63. PubMed ID: 8165703
[TBL] [Abstract][Full Text] [Related]
16. Effects of losartan on the treatment of posttransplant erythrocytosis.
Navarro JF; García J; Macía M; Mora C; Chahin J; Gallego E; Méndez ML; del Castillo N
Clin Nephrol; 1998 Jun; 49(6):370-2. PubMed ID: 9696433
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation.
Yagisawa T; Toma H; Yaguchi H; Tomaru M; Iijima Y; Suzuki H; Nakada T
Int Urol Nephrol; 1997; 29(3):363-7. PubMed ID: 9285312
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
Torregrosa JV; Campistol JM; Montesinos M; Rogada AG; Oppenheimer F; Andreu J
Transplantation; 1994 Aug; 58(3):311-4. PubMed ID: 8053053
[TBL] [Abstract][Full Text] [Related]
19. [Effect of angiotensin-converting enzyme inhibitors on serum levels of erythropoietin in patients on peritoneal dialysis].
Huang YH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jan; 22(1):74-5. PubMed ID: 12390854
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis.
Glicklich D; Burris L; Urban A; Tellis V; Greenstein S; Schechner R; Devarajan P; Croizat H
J Am Soc Nephrol; 2001 Sep; 12(9):1958-1964. PubMed ID: 11518790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]